Americana Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Buy |
8,822
+601
| +7% | +$23.1K | 0.01% | 350 |
|
|
2025
Q1 | $318K | Sell |
8,221
-7,081
| -46% | -$274K | 0.01% | 320 |
|
|
2024
Q4 | $518K | Sell |
15,302
-43,635
| -74% | -$1.48M | 0.02% | 271 |
|
|
2024
Q3 | $2.41M | Buy |
58,937
+243
| +0.4% | +$9.93K | 0.16% | 127 |
|
|
2024
Q2 | $2.26M | Buy |
58,694
+14,039
| +31% | +$540K | 0.18% | 125 |
|
|
2024
Q1 | $1.91M | Sell |
44,655
-2,433
| -5% | -$104K | 0.16% | 135 |
|
|
2023
Q4 | $1.73M | Buy |
47,088
+29,043
| +161% | +$1.06M | 0.16% | 123 |
|
|
2023
Q3 | $643K | Buy |
18,045
+2,267
| +14% | +$80.7K | 0.07% | 183 |
|
|
2023
Q2 | $562K | Buy |
+15,778
| New | +$562K | 0.07% | 182 |
|